- Filed
- Feb 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 10, 2025 | 28.13M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $70.53M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $70M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $49.28M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $62.61M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $56M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $69.36M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $90.65M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $107.12M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $111.26M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $127.85M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 31.84M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 31.99M sh |
| Stock Repurchased | Q2 2025 · Dec 31, 2023 | $3.02M |
| Capex | Q2 2025 · Dec 31, 2023 | $135K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | $15.83M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $66.79M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $64.27M |
| Stockholders Equity | Q2 2025 · Jun 30, 2023 | $61.7M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.07 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | $0.15 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.07 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | $0.15 |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $2.39M |
| Sga Expense | Q2 2025 · Dec 31, 2023 | $5.58M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $6.66M |
| Rd Expense | Q2 2025 · Dec 31, 2023 | $13.29M |
| Net Income | Q2 2025 · Dec 31, 2023 | $2.19M |
| Net Income | Q2 2025 · Dec 31, 2023 | $4.78M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $2.43M |
| Operating Income | Q2 2025 · Dec 31, 2023 | $3.84M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $16.83M |
| Gross Profit | Q2 2025 · Dec 31, 2023 | $34.16M |
| Revenue | Q2 2025 · Dec 31, 2023 | $23.82M |
| Revenue | Q2 2025 · Dec 31, 2023 | $47.99M |